Navigation Links
Baltimore's Mark E. Spier, DPM, Announces FDA Clearance of PinPointe™ FootLaser™ for Treatment of Nail Fungus
Date:10/26/2010

BALTIMORE, Oct. 26 /PRNewswire/ -- The podiatry practice of Mark E. Spier, DPM, announced today that the PinPointe™ FootLaser™ has received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of nail fungus (onychomycosis). Dr. Spier is the first certified provider of the treatment in the Baltimore area.

"Toenail fungus, a condition that affects more than 35 million Americans, is both easily spread and exceptionally durable, often standing up against the most aggressive antifungal pills," said Dr. Spier. "With FDA clearance of the PinPointe FootLaser, patients have a relatively painless, important new treatment option. It is often more successful than topically applied antifungal drugs, has less side effects than oral medication, and is less painful than surgical removal of the nail."

Fungal nail infection is caused by fungus under the nail.  As they grow, fungi feed on keratin, the tough protein that makes up the hard surface of the nails. The nail becomes darker in color and debris may accumulate under the nail. Nail infection can cause nails to be discolored, thickened, brittle, and 'crumbly' and in some people it can interfere with wearing shoes and/or cause pain when walking.

The treatment of nail infection is difficult because the infection is under and inside of the nail, making it hard for any treatment to reach and destroy the infection.  Some people are treated with medicated nail polish or oral medications, which can be associated with side effects and serious drug interactions. Another option is to surgically remove the nail.

About the PinPointe FootLaser

The PinPointe FootLaser is a patented laser device that has been showed in clinical studies to significantly reduce nail infection. The patented PinPointe FootLaser is a specially designed laser beam that goes through the nail and safely reduces the infection in the nail bed that cause onychomycosis. It is FDA cleared and backed by significant clinical research.

The procedure requires one or a small number of safe, quick treatments with little or no discomfort and is performed as an outpatient service with no anesthesia. The gentle laser light beam has no effect on healthy tissue and treats only the infected area.  No drugs or topical ointments are used, eliminating the total-body side effects of traditional oral medications.

About Dr. Mark E. Spier

With 25 years of experience, Dr. Mark E. Spier serves the Baltimore Metropolitan area for all of its podiatry needs. His practice offers care for the full range of foot ailments from fractures to corns. Dr. Spier is certified by the American Board of Podiatric Surgery in forefoot and reconstructive surgery. Visit www.spierfoot.com for more information.

PinPointe and FootLaser are trademarks of PinPointe USA, Inc.


'/>"/>
SOURCE Dr. Mark E. Spier, DPM
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
2. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
3. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
4. NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases
5. Trius Announces Issuance of Key U.S. Patent for Torezolid Phosphate
6. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
7. Roper Industries Announces Record Third Quarter Results
8. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
9. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
10. NCPA Announces Kathleen Jaeger as CEO
11. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... , Feb. 9, 2016  The Parenteral Drug ... professionals developing and manufacturing sterile drug products, today ... Regulatory Guidance Comparison – With link to Comparison ... issued by the U.S. FDA, the EU, the ... --> --> ...
(Date:2/8/2016)... , Feb.8, 2016 Cardiovascular Surgery ... Summary GlobalData,s Medical Devices sector report, "Cardiovascular ... provides an overview of Cardiovascular Surgery Devices currently ... --> The report provides comprehensive information ... the products at various stages of development. The ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , ... and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that they ... development and commercialization rights for OPA-15406 in the U.S. ... also provides manufacturing rights.  OPA-15406 is a topical, non-steroidal ... atopic dermatitis. --> --> ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... February 09, 2016 , ... Center for Autism ... diagnosed with autism spectrum disorder (ASD). Beginning Jan. 1, 2016, Medicaid is covering ... analysis (ABA) is key to providing effective treatment for individuals with ASD. Now, ...
(Date:2/9/2016)... ... February 09, 2016 , ... A new study ... rates and Medicare rates for a variety of medical services in Illinois as ... of the 2015 Fee Schedule Rates in Illinois, are professional medical services, ...
(Date:2/9/2016)... ... February 09, 2016 , ... Establishment Labs, a global breast ... Hung to the company´s Board of Directors. , “We are honored to ... an exceptional entrepreneur.” said Juan Jose Chacon Quiros, CEO of Establishment Labs. "David’s knowledge ...
(Date:2/9/2016)... ... ... Dr. Rassouli, cosmetic dentist in Orange County , is now offering ... procedures in dentistry today, but the cost often leads to patients looking to less ... whitening-related damage. For a limited time, Dr. Rassouli is offering this special whitening package ...
(Date:2/9/2016)... ... , ... Two renowned photographers, Robert Caplin (New York, NY) and Peter Lockley ... 14-19, 2016, hosted by Four Seasons Resort Maui at Wailea as part of the ... 2015, the Maui Photo Expedition workshop will once again consist of on-location ...
Breaking Medicine News(10 mins):